PBS post-market review of biologics

PBS post-market review of biologics

The Pharmaceutical Benefits Scheme (PBS) are undertaking a post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis. Several College Fellows have been involved in the post-market review.

A stakeholder forum was recently held in Melbourne, with College Fellows, consumers and pharmaceutical sponsors invited to participate. A summary of the stakeholder forum has been released and is now available on the PBS website.